GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mereo BioPharma Group PLC (HAM:MAH0) » Definitions » 12-1 Month Momentum %

Mereo BioPharma Group (HAM:MAH0) 12-1 Month Momentum % : N/A% (As of Jun. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Mereo BioPharma Group 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-23), Mereo BioPharma Group's 12-1 Month Momentum % is N/A%.

The industry rank for Mereo BioPharma Group's 12-1 Month Momentum % or its related term are showing as below:

HAM:MAH0's 12-1 Month Momentum % is not ranked *
in the Biotechnology industry.
Industry Median: -21.37
* Ranked among companies with meaningful 12-1 Month Momentum % only.

Competitive Comparison of Mereo BioPharma Group's 12-1 Month Momentum %

For the Biotechnology subindustry, Mereo BioPharma Group's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mereo BioPharma Group's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mereo BioPharma Group's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Mereo BioPharma Group's 12-1 Month Momentum % falls into.



Mereo BioPharma Group  (HAM:MAH0) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mereo BioPharma Group  (HAM:MAH0) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Mereo BioPharma Group 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Mereo BioPharma Group's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mereo BioPharma Group (HAM:MAH0) Business Description

Comparable Companies
Traded in Other Exchanges
Address
One Cavendish Place, 4th Floor, London, GBR, W1G 0QF
Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its oncology product candidate is etigilimab, for patients with solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod.

Mereo BioPharma Group (HAM:MAH0) Headlines

No Headlines